CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors

Hepatology

Volumn 63, Issue 5, 2016, Pages 1544-1559

  Liu, Ming ^a,b   Chen, Leilei ^c   Ma, Ning Fang ^d   Chow, Raymond Kwok Kei ^a,b   Li, Yan ^a,b,e   Song, Yangyang ^c   Chan, Tim Hon Man ^c   Fang, Shuo ^a,b   Yang, Xiaodong ^a,b   Xi, Shaoyan ^e   Jiang, Lingxi ^a,b   Li, Yun ^a,b   Zeng, Ting Ting ^e   Yuan, Yun Fei ^e   Guan, Xin Yuan ^a,b,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 1 LIKE; DNA BINDING PROTEIN; HISTONE; UNCLASSIFIED DRUG; CARBANILAMIDE DERIVATIVE; CHD1L PROTEIN, MOUSE; CHROMATIN; DNA HELICASE; ESRRB PROTEIN, MOUSE; ESTROGEN RECEPTOR; NICOTINAMIDE; SORAFENIB; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; GENE SEQUENCE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINEAGE; CHEMISTRY; HIGH THROUGHPUT SEQUENCING; LIVER NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; DNA HELICASES; DNA-BINDING PROTEINS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; NIACINAMIDE; PHENYLUREA COMPOUNDS; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS;

EID: 84960192545     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28437     Document Type: Article

References (38)

1. Berman JJ. Tumor taxonomy for the developmental lineage classification of neoplasms. BMC Cancer 2004;4:88.
2. Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, et al. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev 2004;18:629-640.
3. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001;98:15149-15154.
4. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567.
5. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12:410-416.
6. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010;(15 Suppl. 4):5-13.
7. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma. Hepatology 2009;49:318-329.
8. Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 2006;6:593-602.
9. Ma NF, Hu L, Fung JM, Xie D, Zheng BJ, Chen L, et al. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology 2008;47:503-510.
10. Chen M, Huang JD, Hu L, Zheng BJ, Chen L, Tsang SL, et al. Transgenic CHD1L expression in mouse induces spontaneous tumors. PLoS One 2009;4:e6727.
11. Chen L, Hu L, Chan TH, Tsao GS, Xie D, Huo KK, et al. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 2009;50:122-129.
12. Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S, et al. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 2010;120:1178-1191.
13. Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J, et al. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut 2011;60:534-543.
14. Ahel D, Horejsí Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 2009;325:1240-1243.
15. Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009;460:863-868.
16. Schnetz MP, Handoko L, Akhtar-Zaidi B, Bartels CF, Pereira CF, Fisher AG, et al. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet 2010;6:e1001023.
17. Chiou SH, Jiang BH, Yu YL, Chou SJ, Tsai PH, Chang WC, et al. Poly(ADP-ribose)polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc. J Exp Med 2013;210:85-98.
18. Snider AC, Leong D, Wang QT, Wysocka J, Yao MW, Scott MP, et al. The chromatin remodeling factor Chd1l is required in the preimplantation embryo. Biol Open 2013;2:121-131.
19. Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev Cell 2010;18:175-189.
20. Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, et al. Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. Nature 2014;513:110-114.
21. Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, et al. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Diagn Pathol 2012;7:44.
22. Chan TH, Chen L, Liu M, Hu L, Zheng BJ, Poon VK, et al. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development. Hepatology 2012;55:491-505.
23. Li Y, Chen L, Chan TH, Liu M, Kong KL, Qiu JL, et al. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Gastroenterology 2013;144:179-191.
24. Reddy ES, Rao VN, Papas TS. The erg gene: a human gene related to the ets oncogene. Proc Natl Acad Sci USA 1987;84:6131-6135.
25. Hunter CS, Rhodes SJ. LIM-homeodomain genes in mammalian development and human disease. Mol Biol Rep 2005;32:67-77.
26. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008;133:1106-1117.
27. Martello G, Sugimoto T, Diamanti E, Joshi A, Hannah R, Ohtsuka S, et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012;11:491-504.
28. Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008;2:437-447.
29. Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 2006;6:593-602.
30. Johnston RN, Pai SB, Pai RB. The origin of the cancer cell: oncogeny reverses phylogeny. Biochem Cell Biol 1992;70:831-834.
31. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-890.
32. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-4751.
33. Kordes C, Häussinger D. Hepatic stem cell niches. J Clin Invest 2013;123:1874-1880.
34. Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet 2014;15:93-106.
35. Ho L, Crabtree GR. Chromatin remodeling during development. Nature 2010;463:474-484.
36. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part I: covalent histone modifications. Trends Mol Med 2007;13:363-372.
37. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med 2007;13:373-380.
38. Weissman B, Knudsen KE. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res 2009;69:8223-8230.